Brainify.AI

📍 New York, United States🗓 Founded 2021👥 12 employees💰 Last funded Nov 2022
Mental Health Care🌐 brainify.ai
Website LinkedIn
Brainify.AI is an AI biomarker platform for the development of novel treatments for depression that increases the likelihood of new treatment approval and increases drug efficacy. We are members of J&J Labs and Merck DSS. Brainify.AI is backed by Merck GHI Fund, Northpond, and Kodori VC
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2021
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Austria
1
United Kingdom
1
Frequently asked questions
Who invested in Brainify.AI?
Brainify.AI has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Brainify.AI last raise funding?
The most recent investment in Brainify.AI recorded on gritt.io was in November 2022.
When was Brainify.AI founded?
Brainify.AI was founded in 2021.
What industry is Brainify.AI in?
Brainify.AI operates in Mental Health Care. Find similar Mental Health Care investors on gritt.io.
Where is Brainify.AI based?
Brainify.AI is headquartered in New York, United States.